Boosting the harvest: drug combo aims to secure life-saving cells for cancer patients
NCT ID NCT05087212
Summary
This study tested how well two drugs (plerixafor and G-CSF) work together to help the body release stem cells into the bloodstream. These stem cells are collected and later used in a transplant to rebuild the immune system after high-dose chemotherapy for multiple myeloma. The main goal was to see if enough cells could be collected quickly and safely for this critical treatment step.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Sites
China, China
Conditions
Explore the condition pages connected to this study.